Skip to main content
Erschienen in: Supportive Care in Cancer 8/2013

01.08.2013 | Original Article

Malignant biliary obstructions: can we predict immediate postprocedural cholangitis after percutaneous biliary drainage?

verfasst von: Shin Ahn, Yoon-Seon Lee, Kyung Soo Lim, Jae-Lyun Lee

Erschienen in: Supportive Care in Cancer | Ausgabe 8/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Percutaneous transhepatic biliary drainage (PTBD) is performed for the palliation of malignant biliary obstructions. The purpose of this study was to identify factors related to the occurrence of immediate cholangitis as a complication after PTBD

Methods

We retrospectively assessed 409 apparently stable patients with malignant biliary obstruction who underwent PTBD between January 2008 and December 2010. New onset cholangitis was defined as fever (>38 °C) that arose within 24 h after the intervention. Variables significantly associated with the occurrence of immediate cholangitis were selected and their odds ratio and 95 % confidence interval were calculated using logistic regression analysis.

Results

There were 106 (25.9 %) cases of immediate cholangitis following PTBD, and among those 106 cases, 45 (42.5 %) had sepsis. In multivariate analysis, history of cholangitis (OR 4.7, 95 % CI 2.45–9.18), biliary drainage within 6 months (OR 2.3, 95 % CI 1.26–4.15), CRP ≥5 mg/dL (OR 2.2, 95 % CI 1.23–4.03), and serum albumin <3 g/dL (OR 1.9, 95 % CI 1.023–3.40) were predictive of immediate cholangitis after PTBD for malignant biliary obstructions.

Conclusions

Cholangitis is a common immediate complication after PTBD. Patients should always be given prophylactic antibiotics before the drainage procedures. The results of this study could highlight the patients who require closer follow-up in order to make PTBD a safer procedure.
Literatur
1.
Zurück zum Zitat Brown KT, Covey AM (2008) Management of malignant biliary obstruction. Tech Vasc Interv Radiol 11:43–50PubMedCrossRef Brown KT, Covey AM (2008) Management of malignant biliary obstruction. Tech Vasc Interv Radiol 11:43–50PubMedCrossRef
2.
Zurück zum Zitat Westwood DA, Fernando C, Connor SJ (2010) Internal–external percutaneous transhepatic biliary drainage for malignant biliary obstruction: a retrospective analysis. J Med Imaging Radiat Oncol 54:108–110PubMedCrossRef Westwood DA, Fernando C, Connor SJ (2010) Internal–external percutaneous transhepatic biliary drainage for malignant biliary obstruction: a retrospective analysis. J Med Imaging Radiat Oncol 54:108–110PubMedCrossRef
3.
4.
Zurück zum Zitat Smith TP, Ryan JM, Niklason LE (2004) Sepsis in the interventional radiology patient. J Vasc Interv Radiol 15:317–325PubMedCrossRef Smith TP, Ryan JM, Niklason LE (2004) Sepsis in the interventional radiology patient. J Vasc Interv Radiol 15:317–325PubMedCrossRef
5.
Zurück zum Zitat Miller MJ, Smith TP, Ryan JM (2006) Sepsis in the interventional radiology patient. Tech Vasc Interv Radiol 9:64–68PubMedCrossRef Miller MJ, Smith TP, Ryan JM (2006) Sepsis in the interventional radiology patient. Tech Vasc Interv Radiol 9:64–68PubMedCrossRef
6.
Zurück zum Zitat Winick AB, Waybill PN, Venbrux AC (2001) Complications of percutaneous transhepatic biliary interventions. Tech Vasc Interv Radiol 4:200–206PubMedCrossRef Winick AB, Waybill PN, Venbrux AC (2001) Complications of percutaneous transhepatic biliary interventions. Tech Vasc Interv Radiol 4:200–206PubMedCrossRef
7.
Zurück zum Zitat Uberoi R, Das N, Moss J, Robertson I (2012) British society of interventional radiology: Biliary drainage and stenting registry (BDSR). Cardiovasc Intervent Radiol 35:127–138PubMedCrossRef Uberoi R, Das N, Moss J, Robertson I (2012) British society of interventional radiology: Biliary drainage and stenting registry (BDSR). Cardiovasc Intervent Radiol 35:127–138PubMedCrossRef
8.
Zurück zum Zitat Ginat D, Saad WE, Davies MG, Saad NE, Waldman DL, Kitanosono T (2011) Incidence of cholangitis and sepsis associated with percutaneous transhepatic biliary drain cholangiography and exchange: a comparison between liver transplant and native liver patients. AJR Am J Roentgenol 196:W73–W77PubMedCrossRef Ginat D, Saad WE, Davies MG, Saad NE, Waldman DL, Kitanosono T (2011) Incidence of cholangitis and sepsis associated with percutaneous transhepatic biliary drain cholangiography and exchange: a comparison between liver transplant and native liver patients. AJR Am J Roentgenol 196:W73–W77PubMedCrossRef
9.
Zurück zum Zitat Tapping CR, Byass OR, Cast JE (2011) Percutaneous transhepatic biliary drainage (PTBD) with or without stenting-complications, re-stent rate and a new risk stratification score. Eur Radiol 21:1948–1955PubMedCrossRef Tapping CR, Byass OR, Cast JE (2011) Percutaneous transhepatic biliary drainage (PTBD) with or without stenting-complications, re-stent rate and a new risk stratification score. Eur Radiol 21:1948–1955PubMedCrossRef
10.
Zurück zum Zitat Tsai HM, Chuang CH, Lin XZ, Chen CY (2009) Factors relating to the short term effectiveness of percutaneous biliary drainage for hilar cholangiocarcinoma. World J Gastroenterol 15:5206–5210PubMedCrossRef Tsai HM, Chuang CH, Lin XZ, Chen CY (2009) Factors relating to the short term effectiveness of percutaneous biliary drainage for hilar cholangiocarcinoma. World J Gastroenterol 15:5206–5210PubMedCrossRef
11.
Zurück zum Zitat Migita K, Watanabe A, Yoshioka T, Kinoshita S, Ohyama T (2009) Clinical outcome of malignant biliary obstruction caused by metastatic gastric cancer. World J Surg 33:2396–2402PubMedCrossRef Migita K, Watanabe A, Yoshioka T, Kinoshita S, Ohyama T (2009) Clinical outcome of malignant biliary obstruction caused by metastatic gastric cancer. World J Surg 33:2396–2402PubMedCrossRef
12.
Zurück zum Zitat McDougall NI, Edmunds SE (2001) An audit of metal stent palliation for malignant biliary obstruction. J Gastroenterol Hepatol 16:1051–1054PubMedCrossRef McDougall NI, Edmunds SE (2001) An audit of metal stent palliation for malignant biliary obstruction. J Gastroenterol Hepatol 16:1051–1054PubMedCrossRef
13.
Zurück zum Zitat Brountzos EN, Ptochis N, Panagiotou I, Malagari K, Tzavara C, Kelekis D (2007) A survival analysis of patients with malignant biliary strictures treated by percutaneous metallic stenting. Cardiovasc Intervent Radiol 30:66–73PubMedCrossRef Brountzos EN, Ptochis N, Panagiotou I, Malagari K, Tzavara C, Kelekis D (2007) A survival analysis of patients with malignant biliary strictures treated by percutaneous metallic stenting. Cardiovasc Intervent Radiol 30:66–73PubMedCrossRef
14.
Zurück zum Zitat Inal M, Akgul E, Aksungur E, Seydaoglu G (2003) Percutaneous placement of biliary metallic stents in patients with malignant hilar obstruction: unilobar versus bilobar drainage. J Vasc Interv Radiol 14:1409–1416PubMedCrossRef Inal M, Akgul E, Aksungur E, Seydaoglu G (2003) Percutaneous placement of biliary metallic stents in patients with malignant hilar obstruction: unilobar versus bilobar drainage. J Vasc Interv Radiol 14:1409–1416PubMedCrossRef
15.
Zurück zum Zitat Venkatesan AM, Kundu S, Sacks D, Wallace MJ, Wojak JC, Rose SC, Clark TW, D’Othee BJ, Itkin M, Jones RS, Miller DL, Owens CA, Rajan DK, Stokes LS, Swan TL, Towbin RB, Cardella JF (2010) Practice guidelines for adult antibiotic prophylaxis during vascular and interventional radiology procedures. Written by the Standards of Practice Committee for the Society of Interventional Radiology and endorsed by the Cardiovascular Interventional Radiological Society of Europe and Canadian Interventional Radiology Association [corrected]. J Vasc Interv Radiol 21:1611–1630, quiz 1631PubMedCrossRef Venkatesan AM, Kundu S, Sacks D, Wallace MJ, Wojak JC, Rose SC, Clark TW, D’Othee BJ, Itkin M, Jones RS, Miller DL, Owens CA, Rajan DK, Stokes LS, Swan TL, Towbin RB, Cardella JF (2010) Practice guidelines for adult antibiotic prophylaxis during vascular and interventional radiology procedures. Written by the Standards of Practice Committee for the Society of Interventional Radiology and endorsed by the Cardiovascular Interventional Radiological Society of Europe and Canadian Interventional Radiology Association [corrected]. J Vasc Interv Radiol 21:1611–1630, quiz 1631PubMedCrossRef
16.
Zurück zum Zitat Cohan RH, Illescas FF, Saeed M, Perlmutt LM, Braun SD, Newman GE, Dunnick NR (1986) Infectious complications of percutaneous biliary drainage. Invest Radiol 21:705–709PubMedCrossRef Cohan RH, Illescas FF, Saeed M, Perlmutt LM, Braun SD, Newman GE, Dunnick NR (1986) Infectious complications of percutaneous biliary drainage. Invest Radiol 21:705–709PubMedCrossRef
17.
Zurück zum Zitat Yu H, Guo Z, Xing W, Guo X, Liu F, Li B (2012) Bile culture and susceptibility testing of malignant biliary obstruction via PTBD. Cardiovasc Intervent Radiol 35:1136–1144PubMedCrossRef Yu H, Guo Z, Xing W, Guo X, Liu F, Li B (2012) Bile culture and susceptibility testing of malignant biliary obstruction via PTBD. Cardiovasc Intervent Radiol 35:1136–1144PubMedCrossRef
18.
Zurück zum Zitat Nomura T, Shirai Y, Hatakeyama K (1999) Bacteribilia and cholangitis after percutaneous transhepatic biliary drainage for malignant biliary obstruction. Dig Dis Sci 44:542–546PubMedCrossRef Nomura T, Shirai Y, Hatakeyama K (1999) Bacteribilia and cholangitis after percutaneous transhepatic biliary drainage for malignant biliary obstruction. Dig Dis Sci 44:542–546PubMedCrossRef
19.
Zurück zum Zitat Covey AM, Brown KT (2008) Percutaneous transhepatic biliary drainage. Tech Vasc Interv Radiol 11:14–20PubMedCrossRef Covey AM, Brown KT (2008) Percutaneous transhepatic biliary drainage. Tech Vasc Interv Radiol 11:14–20PubMedCrossRef
20.
Zurück zum Zitat Ozden I, Tekant Y, Bilge O, Acarli K, Alper A, Emre A, Rozanes I, Ozsut H, Ariogul O (2005) Endoscopic and radiologic interventions as the leading causes of severe cholangitis in a tertiary referral center. Am J Surg 189:702–706PubMedCrossRef Ozden I, Tekant Y, Bilge O, Acarli K, Alper A, Emre A, Rozanes I, Ozsut H, Ariogul O (2005) Endoscopic and radiologic interventions as the leading causes of severe cholangitis in a tertiary referral center. Am J Surg 189:702–706PubMedCrossRef
21.
Zurück zum Zitat van Delden OM, Lameris JS (2008) Percutaneous drainage and stenting for palliation of malignant bile duct obstruction. Eur Radiol 18:448–456PubMedCrossRef van Delden OM, Lameris JS (2008) Percutaneous drainage and stenting for palliation of malignant bile duct obstruction. Eur Radiol 18:448–456PubMedCrossRef
22.
Zurück zum Zitat Ferrucci JT Jr, Mueller PR, Harbin WP (1980) Percutaneous transhepatic biliary drainage: technique, results, and applications. Radiology 135:1–13PubMed Ferrucci JT Jr, Mueller PR, Harbin WP (1980) Percutaneous transhepatic biliary drainage: technique, results, and applications. Radiology 135:1–13PubMed
Metadaten
Titel
Malignant biliary obstructions: can we predict immediate postprocedural cholangitis after percutaneous biliary drainage?
verfasst von
Shin Ahn
Yoon-Seon Lee
Kyung Soo Lim
Jae-Lyun Lee
Publikationsdatum
01.08.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 8/2013
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-013-1796-5

Weitere Artikel der Ausgabe 8/2013

Supportive Care in Cancer 8/2013 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.